SCHEMBL19081544

SCHEMBL19081544

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5cc6c(oc7ccc8ccccc8c76)c6oc7ccccc7c56)cc4)c4ccccc34)cccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALOX5 P09917 1/20 0.36
ALDH1A1 P00352 4/20 0.35
MAPT P10636 4/20 0.35
HSD17B10 Q99714 4/20 0.35
HPGD P15428 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
AHR P35869 4/20 0.34
KDM4E B2RXH2 3/20 0.34
ABCG2 Q9UNQ0 3/20 0.34
CYP1A2 P05177 2/20 0.34
PAX8 Q06710 2/20 0.34
RAB9A P51151 2/20 0.34
CYP2C19 P33261 2/20 0.34
NPC1 O15118 2/20 0.34
CYP1A1 P04798 1/20 0.34
FYN P06241 1/20 0.34
MAPK3 P27361 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081673 0.93 ALOX5 (0.38) TDP1L3MBTL1ALOX5ALDH1A1MAPT
SCHEMBL19081506 0.92 ABCG2 (0.42) TDP1L3MBTL1ALDH1A1MAPTHSD17B10
SCHEMBL17945585 0.92 ALOX5 (0.41) TDP1L3MBTL1ALOX5ALDH1A1MAPT
SCHEMBL19081451 0.92 TDP1 (0.41) TDP1L3MBTL1ALOX5ALDH1A1MAPT
SCHEMBL19081539 0.86 TDP1 (0.37) TDP1L3MBTL1ALOX5ALDH1A1MAPT
SCHEMBL17944847 0.86 ALOX5 (0.41) TDP1L3MBTL1ALOX5ALDH1A1MAPT
SCHEMBL17945226 0.85 ALOX5 (0.39) TDP1L3MBTL1ALOX5ALDH1A1MAPT
SCHEMBL19081598 0.85 TDP1 (0.36) TDP1L3MBTL1ALOX5ALDH1A1MAPT
SCHEMBL17943895 0.84 ALOX5 (0.39) TDP1ALOX5ALDH1A1MAPTHSD17B10
SCHEMBL19081542 0.84 TDP1 (0.37) TDP1L3MBTL1ALOX5ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885ALOX5 1939/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885ALOX5 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.